AU4395399A - Five-membered heteroaryl compounds - Google Patents
Five-membered heteroaryl compoundsInfo
- Publication number
- AU4395399A AU4395399A AU43953/99A AU4395399A AU4395399A AU 4395399 A AU4395399 A AU 4395399A AU 43953/99 A AU43953/99 A AU 43953/99A AU 4395399 A AU4395399 A AU 4395399A AU 4395399 A AU4395399 A AU 4395399A
- Authority
- AU
- Australia
- Prior art keywords
- membered heteroaryl
- heteroaryl compounds
- compounds
- membered
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18733998 | 1998-07-02 | ||
JP10/187339 | 1998-07-02 | ||
PCT/JP1999/003549 WO2000001688A1 (en) | 1998-07-02 | 1999-07-01 | Five-membered heteroaryl compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4395399A true AU4395399A (en) | 2000-01-24 |
Family
ID=16204278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU43953/99A Abandoned AU4395399A (en) | 1998-07-02 | 1999-07-01 | Five-membered heteroaryl compounds |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4395399A (en) |
WO (1) | WO2000001688A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU781552B2 (en) * | 1999-11-12 | 2005-05-26 | Merck Sharp & Dohme Corp. | Diaryl piperidyl pyrrole derivatives as antiprotozoal agents |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6310052B1 (en) | 1996-06-04 | 2001-10-30 | Queen's University At Kingston | Nitrate esters and their use for neurological conditions |
US7301021B2 (en) | 1997-07-02 | 2007-11-27 | Smithkline Beecham Corporation | Substituted imidazole compounds |
ES2221426T3 (en) | 1998-08-20 | 2004-12-16 | Smithkline Beecham Corporation | NEW SUBSTITUTED TRIAZOL COMPOUNDS. |
US6548529B1 (en) | 1999-04-05 | 2003-04-15 | Bristol-Myers Squibb Company | Heterocyclic containing biphenyl aP2 inhibitors and method |
US7122666B2 (en) | 1999-07-21 | 2006-10-17 | Sankyo Company, Limited | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses |
HUP0203403A3 (en) | 1999-11-22 | 2004-01-28 | Smithkline Beecham Plc | New imidazole derivatives, pharmaceutical compositions containing them and their use |
ATE281439T1 (en) | 1999-11-23 | 2004-11-15 | Smithkline Beecham Corp | 3,4-DIHYDRO-(1H)CHINAZOLINE-2-ONE COMPOUNDS AS CSBP/P38 KINASE INHIBITORS |
BR0206533A (en) * | 2001-01-18 | 2003-12-16 | Sankyo Co | Compound, pharmaceutical composition, and use of a compound |
WO2002057255A1 (en) * | 2001-01-22 | 2002-07-25 | Sankyo Company, Limited | 4- or 5-substituted pyrrole derivatives |
JP2005505562A (en) * | 2001-09-05 | 2005-02-24 | スミスクライン ビーチャム パブリック リミテッド カンパニー | Pyridylfuran and pyrrole as Raf kinase inhibitors |
EP1534282B1 (en) | 2002-07-09 | 2006-12-27 | Boehringer Ingelheim Pharma GmbH & Co.KG | Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
US20060035893A1 (en) | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
PE20060777A1 (en) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | INDOLINONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES |
JP5462784B2 (en) | 2007-04-27 | 2014-04-02 | パーデュー、ファーマ、リミテッド、パートナーシップ | TRPV1 antagonists and uses thereof |
EP1992344A1 (en) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation |
PT2723732T (en) | 2011-06-22 | 2017-02-17 | Purdue Pharma Lp | Trpv1 antagonists including dihydroxy substituent and uses thereof |
PL224418B1 (en) | 2012-09-26 | 2016-12-30 | Univ Jagielloński | New pyrrole derivatives and process for their preparation |
US9090618B2 (en) | 2012-12-27 | 2015-07-28 | Purdue Pharma L.P. | Substituted benzimidazole-type piperidine compounds and uses thereof |
US11034669B2 (en) | 2018-11-30 | 2021-06-15 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9300141A (en) * | 1992-01-13 | 1994-07-29 | Smithkline Beecham Corp | NOVEL IMIDAZOLE COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT. |
US5593992A (en) * | 1993-07-16 | 1997-01-14 | Smithkline Beecham Corporation | Compounds |
IL110296A (en) * | 1993-07-16 | 1999-12-31 | Smithkline Beecham Corp | Imidazole compounds process for their preparation and pharmaceutical compositions containing them |
DE69433501T2 (en) * | 1993-11-08 | 2004-11-04 | Smithkline Beecham Corp. | OXAZOLES FOR TREATING CYTOKINE MEDIATED DISEASES |
US5559137A (en) * | 1994-05-16 | 1996-09-24 | Smithkline Beecham Corp. | Compounds |
EP0797575B1 (en) * | 1994-12-13 | 2003-10-15 | F. Hoffmann-La Roche Ag | Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase |
US5908858A (en) * | 1996-04-05 | 1999-06-01 | Sankyo Company, Limited | 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses |
-
1999
- 1999-07-01 AU AU43953/99A patent/AU4395399A/en not_active Abandoned
- 1999-07-01 WO PCT/JP1999/003549 patent/WO2000001688A1/en active Application Filing
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU781552B2 (en) * | 1999-11-12 | 2005-05-26 | Merck Sharp & Dohme Corp. | Diaryl piperidyl pyrrole derivatives as antiprotozoal agents |
Also Published As
Publication number | Publication date |
---|---|
WO2000001688A1 (en) | 2000-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5413600A (en) | Compounds | |
AU1278701A (en) | Novel compounds | |
AU1978699A (en) | Heterocyclic compounds | |
AU4395399A (en) | Five-membered heteroaryl compounds | |
AU2408300A (en) | Novel compounds | |
AU2014800A (en) | Novel compounds | |
AU1746401A (en) | Compounds | |
AU6032100A (en) | New compounds | |
AUPQ441499A0 (en) | Novel compound | |
AU3997700A (en) | Anti-first-pass effect compounds | |
AU1488001A (en) | Stabilized thyroxine compounds | |
AU4132200A (en) | Novel compounds | |
AU5887400A (en) | Derivative compounds | |
AUPP921299A0 (en) | New heterocyclic compounds | |
AU2109700A (en) | Novel compounds | |
AU5787901A (en) | Compound | |
AU1682400A (en) | 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds | |
AU3730699A (en) | Heterocyclic compound | |
AU5119400A (en) | Compounds | |
AU2288900A (en) | Novel compounds | |
AU2725599A (en) | Substituted alxoxycarbonyl compounds | |
AU2668000A (en) | Bis-styrylbiphenyl compounds | |
AU6168900A (en) | Compounds | |
AU1385701A (en) | Novel compounds | |
AU4156800A (en) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |